OXOID
Board
2 directors, 1 auditor, last change in May 2026Director
since 28-06-2024
6-year term from 2024
listed in the 2025 annual accounts, filed on 17-06-2026
Statutory auditor, permanent representative Wouter COPPENS
current term since 12-05-2025
3-year term from 2025
listed in the 2025 annual accounts, filed on 17-06-2026
Mandates through the years
3 names, the dashed line is todayBoardRest of the termmandate already running before its first mention
Mandates as a list
- Anthony SMITH
- Director, from 05-03-2019 to date
- Petrus VAN dER ZANDE
- Director, since before 29-06-2020
- BV PwC Bedrijfsrevisoren
- Statutory auditor, from 01-06-2019 to date
Control
consolidates
This company
OXOID
Equity €663,381
Loss €22,495 in 2025
Capital
- Capital
- €300,000
- Shares
- 11,845 in the 2025 annual accounts
- Contribution per share
- €25.33
- Equity per share
- €56.01 in 2025
- Source
- deed of 28-08-2023
Owners through the years
as the annual accounts name themOwners as a list
- Thermo Fisher Scientific Inc.
Source: parent in its own accounts
Articles of association
deed of 28-08-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Monday of May at 10:00
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Besluit algemene vergadering die beraadslaagt op wijze door wet vereist, ontbinding in bij wet bepaalde gevallen”
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten genoemd in artikel 2:87 Wetboek van vennootschappen en verenigingen zonder bijzondere machtiging algemene vergadering, algemene…”